Intervention to Reduce Bisphenol A Exposure in Women

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03440307

Enrollment

Registered

2018-02-22

Start date

2015-11-12

Completion date

2017-11-11

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Environmental Exposure

Brief summary

The purpose of this study is to determine whether a 3-week intervention reduces urinary Bisphenol A (BPA) in women with obesity

Detailed description

The purpose of this study is reduce BPA exposure in women. The intervention is rooted in social cognitive theory, and is applied to environmental health.

Interventions

BEHAVIORALFace-to-Face Meetings

Participants received health and fitness education, and a face-to-face 3-week intervention to reduce bisphenol exposure.

BEHAVIORALEmail Only

Participants received health and fitness education.

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

PREVENTION

Masking

SINGLE (Outcomes Assessor)

Masking description

Single-blinded study

Intervention model description

Participants randomized to intervention or control.

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 50 Years

Healthy volunteers

Yes

Inclusion criteria

* BMI \>29.9 * Age 18-50 years * Non-smoking * English speaking

Exclusion criteria

* History of infertility * Type 2 or Type 1 diabetes * Cardiovascular disease, or any other metabolic disease/complication * History of major psychiatric illness, drug abuse, or unsafe dieting practices * History of bariatric surgery * Pregnant women or women expecting or trying to become pregnant * Participating in other studies

Design outcomes

Primary

Measure	Time frame	Description
Change from Baseline Urine BPA at 3-weeks	Single urine overnight fasted sample at baseline (date of randomization) and 3-weeks	Change in urinary BPA measured at baseline and 3-weeks

Secondary

Measure	Time frame	Description
Change from Baseline Urine BPS and BPF at 3-weeks	Single urine overnight fasted sample at baseline (date of randomization) and 3-weeks	Change in urinary BPS and BPF measured at baseline and 3-weeks
Change from Baseline Weight at 3-weeks	Overnight fasted weight at baseline (date of randomization) and 3-weeks	Change in body weight measured at baseline and 3-weeks

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 16, 2026